Cactus

Cactus Life Sciences is a private medical and scientific communications company serving biopharma, pharmaceutical, biotechnology, and medical device clients. Rather than developing therapeutics, the company provides strategy and execution across the product lifecycle, including scientific and medical communications, publications, meetings and events, patient engagement, HEOR support, medical excellence, and global capability center advisory services. The business emphasizes science-led delivery combined with technology-enabled workflows and AI tools to help clients scale content creation and medical affairs operations. Headquartered in Princeton, New Jersey, it has an international footprint spanning the United States, United Kingdom, Switzerland, India, and Japan. In 2024, the company expanded through the acquisition of nspm and eluSCIdate, strengthening its rare disease and events capabilities.